Clop 75 Tablet
Marketer
West-Coast Pharmaceutical Works Ltd
Salt Composition
Clopidogrel (75mg)
Overview Clop 75 Tablet
CardioGuard 75mg tablets are antiplatelet agents, effectively reducing the risk of dangerous blood clot formation within blood vessels. This minimizes the likelihood of heart attack or stroke, making it a common preventative medication for cardiovascular health. CardioGuard 75mg is prescribed for individuals at elevated risk of heart disease, encompassing those with peripheral arterial disease (circulatory issues due to constricted blood vessels), recent stroke or myocardial infarction, arrhythmias, and post-stenting patients. It also features in combined therapies for treating heart attacks and unstable angina. Administration is independent of meals, consistently at the same time daily. Continuous use is crucial; cessation increases the risk of cardiovascular events. The most prevalent adverse effect is bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual flow. Wound healing may be prolonged. While typically mild and self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in individuals with active bleeding, such as from peptic ulcers or intracranial hemorrhage. Prior blood clotting disorders, recent major trauma, or upcoming surgery necessitate prior consultation with a physician. Temporary discontinuation may be required before scheduled surgical or dental procedures.
Primary Ingredients of Clop 75 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Clop 75 Tablet
Avoiding heart attacks and strokes
Major Benefits of Clop 75 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clop 75 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Clop 75 Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Clop 75 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clop 75 Tablets can be consumed with or without food; however, consistent timing is recommended.
How Clop 75 Tablet works:
Ticagrelor 75 mg tablets are a type of antiplatelet drug. Their mechanism of action involves inhibiting platelet aggregation, thus reducing the risk of dangerous thrombus development. This ultimately diminishes the likelihood of experiencing a myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Clop 75 Tablet necessitates caution. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Clop 75 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Clop 75 Tablet use appear compatible. Available human data indicates minimal infant risk associated with the medication.
DrivingSAFE
Driving ability is typically unaffected by Clop 75 Tablet.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment may safely use Clop 75 Tablet without requiring any alteration to the prescribed dosage.
LiverSAFE IF PRESCRIBED
Clop 75 Tablets may be administered to patients with hepatic impairment without requiring dosage modification.
What if you forget to take Clop 75 Tablet :
Should you forget a Clop 75 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Clop 75 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Amino acid alpha esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |



